Compare AORT & GSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AORT | GSBD |
|---|---|---|
| Founded | 1984 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 974.8M |
| IPO Year | 1996 | 2013 |
| Metric | AORT | GSBD |
|---|---|---|
| Price | $27.23 | $9.80 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 2 |
| Target Price | ★ $49.40 | $9.00 |
| AVG Volume (30 Days) | 550.4K | ★ 862.1K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 13.49% |
| EPS Growth | ★ 165.62 | 87.27 |
| EPS | 0.03 | ★ 0.09 |
| Revenue | ★ $298,836,000.00 | N/A |
| Revenue This Year | $14.20 | N/A |
| Revenue Next Year | $11.20 | N/A |
| P/E Ratio | $886.00 | ★ N/A |
| Revenue Growth | ★ 18.01 | N/A |
| 52 Week Low | $19.16 | $8.36 |
| 52 Week High | $48.25 | $11.62 |
| Indicator | AORT | GSBD |
|---|---|---|
| Relative Strength Index (RSI) | 57.36 | 55.52 |
| Support Level | $19.49 | $9.08 |
| Resistance Level | $37.65 | $9.11 |
| Average True Range (ATR) | 0.95 | 0.20 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 54.28 | 90.37 |
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Goldman Sachs BDC Inc is a non-diversified, closed-end management investment company that elected to be regulated as a business development company focused on lending to middle-market companies. The investment objective is to generate current income and, to a lesser extent, capital appreciation through direct originations of secured debt, including the first lien, unitranche and second lien debt, and unsecured debt. It invests in U.S. middle-market companies such as banks and the public debt markets. The company focuses on the negotiation and structuring of the loans or securities in which it invests and holding the investments in its portfolio to maturity. It generates majority revenue in the form of interest income and dividend income.